Tirzepatide represents a groundbreaking therapeutic agent for individuals facing type 2 diabetes. As a dual receptor activator, it targets both the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic https://allenbddf580575.blogofchange.com/41195649/tirzepatide-a-new-frontier-in-diabetes-treatment